Dr. Jacquelyn Cragg

Research Interests

; ; ; ;

Dr. Jacquelyn Cragg aims to be a world leader in neuro-analytics, helping to uncover innovative treatment strategies and therapies for people suffering from neurological diseases. She is working with statistical algorithms to better understand neurological diseases, including Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and SCI.

Dr. Jacquelyn Cragg is an Assistant Professor in UBC’s Faculty of Pharmaceutical Sciences and a Principal Investigator at ICORD. She is leveraging clinical and population “big data” sources and machine-based learning to identify novel, reliable predictors of spinal cord injury progression. She also researches other neurological diseases beyond spinal cord injury, such as Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS).

As the sole North American recipient of L’Oréal-UNESCO for Women In Science International Rising Talent Prize for 2019, Dr. Cragg is a champion for encouraging women and girls to pursue careers in science.

Techniques employed in the Lab

  • Longitudinal analysis
  • Meta-analysis
  • Statistical learning
  • Recursive partitioning
  • Survival analysis
  • Causal inference

Awards

Some of Dr. Cragg’s recent major awards and accomplishments include:

  • Recognition by L’Oreal Canada in L’Oreal-UNESCO for Women in Science Celebration (8500+views):https://twitter.com/i/status/1624423017265905668
  • Michael Smith Health Research BC Scholar Award (2021-2026)
  • Canadian Society for Epidemiology & Biostatistics (CSEB) Early Career Award (2021)
  • Canadian Society for Pharmaceutical Sciences (CSPS) Early Career Award (2021)
  • Tier 2 Canada Research Chair (Canada Research Chairs, 2020-2025)
  • YWCA Women of Distinction Award (2024)
  • Brain MacMahon Early Career Epidemiologist Award (Society for Epidemiologic Research, 2024)
  • Association of Faculties of Pharmacy of Canada (AFPC) New Investigator Research Award [national award] (2024)
  • King Charles Coronation Medal (Government of Canada, Chancellery of Honours at Rideau Hall, 2025)

Current Lab Members

Ph.D. Students Postdoctoral Fellows Research Staff
Tiffany Price James Crispo Lisa Kuramoto
Analisa Jia
Anh Khoa Vo

Trainee Awards

Year Name Award
2024 James Crispo UBC PharmSci Postdoctoral Fellow Pathway to Independence Research Grant ($10,000), UBC Faculty of Pharmaceutical Sciences
2024 James Crispo Gordon Heibert Award Poster Award, ICORD Annual Research Meeting
2024 Analisa Jia Ernest Bors Award (best paper published by young investigator in the Journal of Spinal Cord Medicine in 2024)
2023-2026 Analisa Jia CIHR Doctoral Award (CGS-D; $105,000)
2023 Analisa Jia Best PhD Poster Award, PharmSci Graduate and Postdoctoral Research Symposium, UBC Faculty of Pharmaceutical Sciences
2022-2026 Analisa Jia Four Year Doctoral Fellowship, UBC
2022-2024 Anh Koa Vo Mitacs Accelerate
2022 Analisa Jia Best Poster Award, PharmSci Graduate and Postdoctoral Research Symposium 2022
2021-2024 Dr. James Crispo Michael Smith Health Research BC Trainee Award
2021 Analisa Jia Syd Vernon Graduate Student Award, UBC Faculty of Graduate Studies
2021 Analisa Jia 3 Minute Thesis (3MT), Faculty of Pharmaceutical Sciences, 1st Prize (UBC PharmSci, 2021)
2020 Analisa Jia Summer Student Research Program 1st Prize (poster presentation) (UBC PharmSci, 2020)

Current Opportunities in the Lab

There are currently no openings in Dr. Cragg’s lab. Please contact Dr. Cragg with inquiries.

Recent publications

  • Tong, B et al.. 2026. Temporal trends in gabapentinoid use for the acute management of spinal cord injury: a retrospective cohort study.. Spinal Cord. doi: 10.1038/s41393-026-01172-7.
  • Chang, CY, Nasreen, S, Sadarangani, M, Cragg, JJ, Marra, F. 2026. Effect of pneumococcal conjugate vaccine booster dose on prevention of invasive pneumococcal disease in British Columbia, 2003-2018.. Vaccine. doi: 10.1016/j.vaccine.2025.128066.
  • Sawicka, KM et al.. 2025. A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors.. Mult Scler Relat Disord. doi: 10.1016/j.msard.2025.106816.
  • Cheng, V et al.. 2025. Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework.. Rheumatol Int. doi: 10.1007/s00296-025-05968-3.
  • Rebić, N et al.. 2025. Impact of the COVID-19 Pandemic on Adherence to Most Costly Chronic Disease Medications in British Columbia, Canada: A Population-Based Interrupted Time Series Analysis.. Patient Prefer Adherence. doi: 10.2147/PPA.S529666.
Search PubMed